CRP and colorectal carcinoma: Previous studies have reported that the peripheral inflammation markers, including the levels of CRP, GPS, and CAR, are related to the prognosis of CRC patients (Ishizuka et al., 2016; Chen et al., 2017), and this was confirmed in our study.